ABBV
$205.07-1.16 (-0.56%)
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Beh...
Recent News
The Market’s Favorite Active ETF Was Made for This Moment. Is It Delivering?
JPMorgan Equity Premium Income ETF (JEPI) is built to cushion volatility, but investors may find stronger returns in defensive sectors and dividend funds.
Protagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's Why
PTGX stock jumps as JNJ wins FDA nod for Icotyde in plaque psoriasis, unlocking milestone payments and royalty potential for Protagonist.
Is AbbVie (ABBV) Quietly Rewiring Its Immunology Edge With Alloy’s Antibody Discovery Deal?
On 17 March 2026, Alloy Therapeutics announced a multi-year agreement giving AbbVie access to its ATX-Gx-based antibody discovery platform, with Alloy receiving an upfront payment and additional compensation upon delivering the platform. This collaboration adds another specialized discovery engine to AbbVie’s research toolkit, potentially broadening its ability to address complex biological targets beyond its current technologies. We’ll now examine how AbbVie’s access to Alloy’s antibody...
The Only 3 Growth ETFs I Would Buy and Hold Through Any Market
Growth investing has had a choppy start to 2026. The major growth benchmarks are down in the low single digits year-to-date, and some of the biggest names in tech have pulled back meaningfully from their late-2025 highs. For investors with a multi-year horizon, that kind of consolidation is worth understanding in the context of each ... The Only 3 Growth ETFs I Would Buy and Hold Through Any Market
Best Healthcare Stocks to Buy After the Market Pullback
They have the means to recover from recent setbacks.